Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis vaccine candidate.

GSK692342 - GSK, Bill & Melinda Gates Foundation

http://www.ncbi.nlm.nih.gov/pubmed/39805855

Alberta Ateere; Alexandre Richard; Céline Lemoine; Christopher J De Voss; Elena Stylianou; Geraldine Frank; Helen McShane; Marcellus Korompis; Salem Salman Almujri; Shuailin Li

Jan 14, 2025